Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diquafosol in type 2 diabetic dry eye
NCT04980144Unknown
- Sponsor
- He Eye Hospital
- Start
- Mar 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of diquafosol in dry eye disease (DED), sponsored by He Eye Hospital. Primary endpoint: Non-invasive tear break-up time at 8 weeks. Status: unknown.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04980144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04980144.